Blocking GABA production caused motor deficits and motor neuron loss in rats
Original source
Inhibition of Glutamate Decarboxylase in the Spinal Cord Induces Motor Deficits and Motor Neuron Degeneration. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Animal
Repeatedly blocking the enzyme glutamate decarboxylase in rats reduced its activity and caused movement changes, cellular changes and the loss of 35–50% of spinal motor neurons. A single dose had no measured effect. The findings suggest that altered gamma-aminobutyric acid (GABA) metabolism may contribute to motor neuron damage, but they do not establish a treatment for amyotrophic lateral sclerosis (ALS).
Why this matters
This is an early laboratory finding in rats, not evidence of benefit or harm from changing GABA metabolism in people with ALS. It may help researchers investigate how spinal motor neurons become damaged, but it does not currently change patient care.
Limitations and context
The study used rats given three experimental glutamate decarboxylase inhibitors, rather than testing a treatment in people with ALS. The findings were based on repeated dosing over 3 or 10 days and do not show that the same process causes ALS in humans. This account relies on one primary research report; longer-term studies and human research would be needed.